We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top-Ranked ETFs That Are Worth Adding to Your Investment Radar
Read MoreHide Full Article
Key Takeaways
Rising volatility makes top-ranked ETFs worth considering for portfolio diversification & greater resilience.
Inflation, higher rate expectations and AI concerns are reinforcing the case for portfolio diversification.
Diversifying across defensive and growth-oriented strategies may help balance portfolio exposure.
The equity market outlook remains clouded by a combination of economic and geopolitical risks, keeping volatility elevated and challenging investors. Persistent inflation, expectations of further Fed rate hikes, geopolitical tensions and growing concerns surrounding AI-related investments have added to market uncertainty, making it increasingly difficult for investors to navigate equities with confidence.
The CBOE Volatility Index (VIX), which measures market expectations of near-term volatility, underscores the growing unease among investors. The index has risen about 3.8% over the previous trading session, taking its gains to approximately 25% over the past month and 35% year to date.
The performance of the S&P 500 Index further highlights the challenging environment. The broad market index is down 0.24% in November so far and approximately 1.17% quarter to date. Against this backdrop, ETFs carrying a Zacks ETF Rank #1 (Strong Buy) could merit investors' attention, particularly those mentioned below.
Why These Top-Ranked ETFs Deserve Your Attention
The following ETFs boast a Zacks ETF Rank #1 and have demonstrated strong performance, making them stand out in the current market environment. These funds offer relatively defensive exposure, while their favorable rankings and solid track records make them worth considering for investors looking to navigate the prevailing market uncertainty.
With capital preservation and portfolio stability taking precedence amid rising economic and market uncertainties, these ETFs could be attractive options for investors. Increasing exposure to defensive funds can help diversify portfolio risks and potentially improve resilience during market downturns.
Their strong Zacks rankings and performance records make them worth considering for investors looking to diversify their holdings and capitalize on potential opportunities across the market.
State Street Health Care Select Sector SPDR ETF (XLV - Free Report)
The U.S. healthcare sector appears to be gaining momentum, with several favorable developments creating potential tailwinds for the industry. Expectations of a more favorable regulatory environment following the U.S. midterm elections, along with increasing macroeconomic uncertainty, rising M&A activity and improving corporate health could make XLV an attractive option for investors.
Healthcare is traditionally considered a non-cyclical sector, offering a defensive tilt to portfolios during periods of market turbulence. Its relative resilience during economic slowdowns and uncertain market conditions often makes it an attractive destination for investors seeking stability and diversification.
The healthcare sector's recent performance points to growing investor interest. The Dow Jones U.S. Health Care Index has gained approximately 10.6% so far in the current quarter and 20.8% year to date, significantly outperforming the S&P 500.
Investors may also consider Vanguard Health Care Index Fund ETF Shares (VHT - Free Report) , which carries a Zacks ETF Rank #1. Both XLV and VHT have a medium risk outlook, making them worth considering for investors seeking exposure to the healthcare sector.
Regarding annual fees, both funds charge nearly similar annual fees, with XLV being the cheapest option, charging 0.08%, compared with VHT's 0.09%. Their dividend yields are also comparable, at 1.35% and 1.33%, respectively.
The funds also share identical top 10 holdings, although their portfolio weightings differ. XLV is both the largest and most liquid of the abovementioned healthcare ETFs, with an asset base of $50.49 billion and a one-month average trading volume of 10.92 million shares.
Vanguard Dividend Appreciation Index Fund ETF Shares (VIG - Free Report)
Amid persistent inflationary pressures, rising expectations of another Federal Reserve rate hike in December and volatility stemming from uncertainty surrounding AI investments and the broader technology sector, VIG could be an attractive option for investors seeking greater portfolio stability.
Dividend-paying stocks can provide investors with a relatively reliable source of income, particularly during periods of heightened equity market volatility. These stocks offer dual advantages — safety, in the form of payouts, and stability in the form of mature companies that are less volatile to large swings in stock prices. Companies offering dividends often act as a hedge against economic uncertainty. Furthermore, incorporating dividend ETFs into an investment portfolio can enhance diversification.
VIG has a dividend yield of 1.45%. Investors can also consider iShares CoreDividend Growth ETF (DGRO - Free Report) , which has a dividend yield of 1.82%. Both funds also have a Medium Risk Outlook.
VIG is the cheapest option, charging 0.04%. Both ETFs have double-digit exposure to the financials, healthcare and information technology sectors. These three sectors also represent the largest allocations in both VIG and DGRO, although their portfolio weightings differ.
Value investing could prove particularly compelling in today's economic environment. Investors are increasingly looking beyond growth-oriented stocks as persistent inflation, higher interest rate expectations and AI-related uncertainty weigh on market sentiment, rotating into defensive funds.
This shift could benefit value-oriented strategies, making VTV an attractive option for investors seeking exposure to relatively undervalued companies. Value ETFs offer an accessible way to capitalize on this investment strategy. Value ETFs focus on stocks characterized by strong fundamentals and robust financial health, which trade below their intrinsic value.
The S&P 500 Value has gained approximately 6% so far in the current quarter and about 14% year to date, outperforming the S&P 500. Investors can also consider iShares Russell 1000 Value ETF (IWD - Free Report) .
Both VTV and IWD carry a Medium Risk Outlook and have double-digit exposure to the financials, healthcare and industrials sectors. However, information technology represents IWD's largest sector allocation, highlighting a difference in the funds' sector positioning.
In terms of size and liquidity, VTV has an edge over IWD. It is the larger and more actively traded of the two funds, with an asset base of $195.75 billion and a one-month average trading volume of 3.19 million shares. VTV is also the cheaper option, charging an annual expense ratio of just 0.03%.
The ETFs discussed above offer relatively defensive investment exposure, reflecting the growing appeal of strategies that could provide greater resilience amid persistent economic and market uncertainties.
However, investors who do not want to completely sacrifice growth potential may consider SPGP, which follows a growth at a reasonable price (GARP) strategy, combining elements of both value and growth investing.
GARP investing seeks to identify companies with attractive growth prospects that are available at reasonable valuations. By balancing growth potential with valuation discipline, this approach offers a middle ground between pure growth and value investing. It may appeal to investors seeking exposure to companies with solid growth prospects while avoiding excessive valuations, particularly during periods of heightened market volatility.
The S&P 500 GARP Index has gained approximately 6.8% so far in the current quarter and about 11.5% year to date, outperforming the S&P 500.
SPGP has the highest allocation to financials with an exposure of 32.92%, followed by double-digit allocations to information technology (15.93%), consumer discretionary (14.49%), industrials (12.95%) and healthcare (10.90%).
The fund has amassed an asset base of $2.19 billion and a one-month average trading volume of about 71,000 shares. SPGP charges an annual fee of 0.34% and has a dividend yield of 0.76%.
Image: Bigstock
Top-Ranked ETFs That Are Worth Adding to Your Investment Radar
Key Takeaways
The equity market outlook remains clouded by a combination of economic and geopolitical risks, keeping volatility elevated and challenging investors. Persistent inflation, expectations of further Fed rate hikes, geopolitical tensions and growing concerns surrounding AI-related investments have added to market uncertainty, making it increasingly difficult for investors to navigate equities with confidence.
The CBOE Volatility Index (VIX), which measures market expectations of near-term volatility, underscores the growing unease among investors. The index has risen about 3.8% over the previous trading session, taking its gains to approximately 25% over the past month and 35% year to date.
The performance of the S&P 500 Index further highlights the challenging environment. The broad market index is down 0.24% in November so far and approximately 1.17% quarter to date. Against this backdrop, ETFs carrying a Zacks ETF Rank #1 (Strong Buy) could merit investors' attention, particularly those mentioned below.
Why These Top-Ranked ETFs Deserve Your Attention
The following ETFs boast a Zacks ETF Rank #1 and have demonstrated strong performance, making them stand out in the current market environment. These funds offer relatively defensive exposure, while their favorable rankings and solid track records make them worth considering for investors looking to navigate the prevailing market uncertainty.
With capital preservation and portfolio stability taking precedence amid rising economic and market uncertainties, these ETFs could be attractive options for investors. Increasing exposure to defensive funds can help diversify portfolio risks and potentially improve resilience during market downturns.
Their strong Zacks rankings and performance records make them worth considering for investors looking to diversify their holdings and capitalize on potential opportunities across the market.
State Street Health Care Select Sector SPDR ETF (XLV - Free Report)
The U.S. healthcare sector appears to be gaining momentum, with several favorable developments creating potential tailwinds for the industry. Expectations of a more favorable regulatory environment following the U.S. midterm elections, along with increasing macroeconomic uncertainty, rising M&A activity and improving corporate health could make XLV an attractive option for investors.
Healthcare is traditionally considered a non-cyclical sector, offering a defensive tilt to portfolios during periods of market turbulence. Its relative resilience during economic slowdowns and uncertain market conditions often makes it an attractive destination for investors seeking stability and diversification.
The healthcare sector's recent performance points to growing investor interest. The Dow Jones U.S. Health Care Index has gained approximately 10.6% so far in the current quarter and 20.8% year to date, significantly outperforming the S&P 500.
Investors may also consider Vanguard Health Care Index Fund ETF Shares (VHT - Free Report) , which carries a Zacks ETF Rank #1. Both XLV and VHT have a medium risk outlook, making them worth considering for investors seeking exposure to the healthcare sector.
Regarding annual fees, both funds charge nearly similar annual fees, with XLV being the cheapest option, charging 0.08%, compared with VHT's 0.09%. Their dividend yields are also comparable, at 1.35% and 1.33%, respectively.
The funds also share identical top 10 holdings, although their portfolio weightings differ. XLV is both the largest and most liquid of the abovementioned healthcare ETFs, with an asset base of $50.49 billion and a one-month average trading volume of 10.92 million shares.
Vanguard Dividend Appreciation Index Fund ETF Shares (VIG - Free Report)
Amid persistent inflationary pressures, rising expectations of another Federal Reserve rate hike in December and volatility stemming from uncertainty surrounding AI investments and the broader technology sector, VIG could be an attractive option for investors seeking greater portfolio stability.
Dividend-paying stocks can provide investors with a relatively reliable source of income, particularly during periods of heightened equity market volatility. These stocks offer dual advantages — safety, in the form of payouts, and stability in the form of mature companies that are less volatile to large swings in stock prices. Companies offering dividends often act as a hedge against economic uncertainty. Furthermore, incorporating dividend ETFs into an investment portfolio can enhance diversification.
VIG has a dividend yield of 1.45%. Investors can also consider iShares Core Dividend Growth ETF (DGRO - Free Report) , which has a dividend yield of 1.82%. Both funds also have a Medium Risk Outlook.
VIG is the cheapest option, charging 0.04%. Both ETFs have double-digit exposure to the financials, healthcare and information technology sectors. These three sectors also represent the largest allocations in both VIG and DGRO, although their portfolio weightings differ.
Vanguard Morningstar Value ETF (VTV - Free Report)
Value investing could prove particularly compelling in today's economic environment. Investors are increasingly looking beyond growth-oriented stocks as persistent inflation, higher interest rate expectations and AI-related uncertainty weigh on market sentiment, rotating into defensive funds.
This shift could benefit value-oriented strategies, making VTV an attractive option for investors seeking exposure to relatively undervalued companies. Value ETFs offer an accessible way to capitalize on this investment strategy. Value ETFs focus on stocks characterized by strong fundamentals and robust financial health, which trade below their intrinsic value.
The S&P 500 Value has gained approximately 6% so far in the current quarter and about 14% year to date, outperforming the S&P 500. Investors can also consider iShares Russell 1000 Value ETF (IWD - Free Report) .
Both VTV and IWD carry a Medium Risk Outlook and have double-digit exposure to the financials, healthcare and industrials sectors. However, information technology represents IWD's largest sector allocation, highlighting a difference in the funds' sector positioning.
In terms of size and liquidity, VTV has an edge over IWD. It is the larger and more actively traded of the two funds, with an asset base of $195.75 billion and a one-month average trading volume of 3.19 million shares. VTV is also the cheaper option, charging an annual expense ratio of just 0.03%.
Invesco S&P 500 GARP ETF (SPGP - Free Report)
The ETFs discussed above offer relatively defensive investment exposure, reflecting the growing appeal of strategies that could provide greater resilience amid persistent economic and market uncertainties.
However, investors who do not want to completely sacrifice growth potential may consider SPGP, which follows a growth at a reasonable price (GARP) strategy, combining elements of both value and growth investing.
GARP investing seeks to identify companies with attractive growth prospects that are available at reasonable valuations. By balancing growth potential with valuation discipline, this approach offers a middle ground between pure growth and value investing. It may appeal to investors seeking exposure to companies with solid growth prospects while avoiding excessive valuations, particularly during periods of heightened market volatility.
The S&P 500 GARP Index has gained approximately 6.8% so far in the current quarter and about 11.5% year to date, outperforming the S&P 500.
SPGP has the highest allocation to financials with an exposure of 32.92%, followed by double-digit allocations to information technology (15.93%), consumer discretionary (14.49%), industrials (12.95%) and healthcare (10.90%).
The fund has amassed an asset base of $2.19 billion and a one-month average trading volume of about 71,000 shares. SPGP charges an annual fee of 0.34% and has a dividend yield of 0.76%.